Ayala Pharmaceuticals Prix / Ventes
Quel est le Prix / Ventes de Ayala Pharmaceuticals?
Le Prix / Ventes de Ayala Pharmaceuticals Inc. est 9.81
Quelle est la définition de Prix / Ventes?
Le rapport prix / ventes est le prix des actions d'une entreprise par rapport à ses revenus.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Prix / Ventes des entreprises dans Health Care secteur sur NASDAQ par rapport à Ayala Pharmaceuticals
Que fait Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Entreprises avec prix / ventes similaire à Ayala Pharmaceuticals
- Indiabulls Ventures a Prix / Ventes de 9.78
- Allspring Income Opportunities Fund a Prix / Ventes de 9.78
- Oxford Immunotec Global PLC a Prix / Ventes de 9.79
- Empress Royalty a Prix / Ventes de 9.79
- Vertex Pharmaceuticals a Prix / Ventes de 9.80
- Novozymes A/S a Prix / Ventes de 9.80
- Ayala Pharmaceuticals a Prix / Ventes de 9.81
- Fatfish Blockchain a Prix / Ventes de 9.81
- Identitii a Prix / Ventes de 9.81
- Krungthai Card Public a Prix / Ventes de 9.81
- Vitalharvest Freehold Trust a Prix / Ventes de 9.81
- HKE a Prix / Ventes de 9.81
- Sabre Resources a Prix / Ventes de 9.82